AU Stock MarketDetailed Quotes

ACL Australian Clinical Labs Ltd

Watchlist

3.630
-0.110-2.94%

20min DelayMarket Closed Oct 4 16:00 AET

732.66MMarket Cap30.25P/E (Static)

Australian Clinical Labs Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2024

(Q4)Jun 30, 2024

(FY)Jun 30, 2023

(Q4)Jun 30, 2023

(FY)Jun 30, 2022

(Q4)Jun 30, 2022

(FY)Jun 30, 2021

(FY)Dec 30, 2020

Assets

Current assets

Cash, cash equivalents and short term investments

30.97%26.14M

-24.33%19.96M

-25.15%26.37M

--26.37M

252.33%35.23M

--10M

-Cash and cash equivalents

30.97%26.14M

-24.33%19.96M

-25.15%26.37M

--26.37M

252.33%35.23M

--10M

-Accounts receivable

23.18%63.26M

-20.86%51.35M

47.08%64.89M

--64.89M

-17.85%44.12M

--53.7M

-Notes receivable

10.35%3.4M

13.68%3.08M

6.10%2.71M

--2.71M

--2.56M

----

-Other receivables

14.62%26.82M

-28.49%23.4M

27.80%32.72M

--32.72M

--25.6M

----

Current deferred assets

----

4,696.15%1.25M

--26K

----

Total current assets

15.21%133.6M

-18.84%115.96M

21.88%142.87M

--142.87M

39.06%117.23M

--84.3M

Non current assets

-Accumulated depreciation

-10.83%-129.79M

65.70%-117.1M

-44.30%-341.38M

---341.38M

---236.58M

----

-Long term equity investment

-5.13%204.19M

28.41%215.23M

-25.19%167.61M

--167.61M

12.48%224.06M

--199.2M

Non current note receivables

30.49%10.74M

-12.61%8.23M

-39.71%9.42M

--9.42M

-32.94%15.63M

--23.3M

-Goodwill

-0.14%164.94M

-0.14%165.17M

46.49%165.4M

--165.4M

9.09%112.91M

--103.5M

Regulatory assets

10.48%81.43M

-19.10%73.71M

44.68%91.11M

--91.11M

17.27%62.98M

--53.7M

Liabilities

Current liabilities

Current debt and capital lease obligation

3.59%104.71M

6.67%101.09M

34.98%94.77M

--94.77M

9.36%70.21M

--64.2M

-Current debt

----

36.67%-190K

---300K

-Current capital lease obligation

3.59%104.71M

6.67%101.09M

34.62%94.77M

--94.77M

9.14%70.4M

--64.5M

-accounts payable

45.76%26.19M

-32.12%17.97M

55.47%26.47M

--26.47M

-57.44%17.03M

--40M

-Total tax payable

-4.91%207.59M

28.18%218.32M

-24.84%170.32M

--170.32M

11.25%226.61M

--203.7M

-Other payable

86.14%2.07M

640.67%1.11M

--150K

----

Current provisions

3.78%1.59M

-79.37%1.54M

26.56%7.44M

--7.44M

-86.76%5.88M

--44.4M

Current deferred liabilities

40,350.00%3.24M

-99.86%8K

39.75%5.62M

--5.62M

-44.19%4.02M

--7.2M

Current liabilities

10.52%207.7M

-16.54%187.93M

35.50%225.16M

--225.16M

6.59%166.18M

--155.9M

Non current liabilities

-Long term debt

-0.28%149.13M

-10.78%149.54M

34.58%167.61M

--167.61M

30.28%124.54M

--95.6M

Non current accrued expenses

-2.33%281.7M

-7.02%288.44M

35.49%310.2M

--310.2M

17.65%228.94M

--194.6M

Long term provisions

-16.18%55.06M

--65.7M

----

-3.95%99.51M

--103.6M

Employee benefits

10.35%3.4M

13.68%3.08M

6.10%2.71M

--2.71M

--2.56M

----

Regulatory liabilities

-75.97%-9.87M

-33.51%-5.61M

-79.29%-4.2M

---4.2M

---2.34M

----

Preferred securities outside stock equity

1.89%44.62M

-5.49%43.79M

8.33%46.33M

--46.33M

--42.77M

----

Total non current liabilities

2.23%415.3M

2.72%406.24M

0.69%395.49M

--395.49M

9.23%392.79M

--359.6M

Shareholders'equity

Share capital

-0.05%791.76M

-0.11%792.14M

-0.62%793.03M

--793.03M

1,594.21%797.98M

--47.1M

-common stock

-0.05%791.76M

-0.11%792.14M

-0.62%793.03M

--793.03M

1,594.21%797.98M

--47.1M

Gains losses not affecting retained earnings

0.22%-773.29M

0.24%-774.96M

0.19%-776.81M

---776.81M

---778.27M

----

Other equity interest

12.18%709K

-44.27%632K

8.10%1.13M

--1.13M

-83.61%1.05M

--6.4M

Total equity

2.44%593.06M

-7.82%578.91M

32.30%628.04M

--628.04M

16.72%474.7M

--406.7M

	(FY)Jun 30, 2024	(Q4)Jun 30, 2024	(FY)Jun 30, 2023	(Q4)Jun 30, 2023	(FY)Jun 30, 2022	(Q4)Jun 30, 2022	(FY)Jun 30, 2021	(FY)Dec 30, 2020
Assets
Current assets
Cash, cash equivalents and short term investments	30.97%26.14M	30.97%26.14M	-24.33%19.96M	-24.33%19.96M	-25.15%26.37M	--26.37M	252.33%35.23M	--10M
-Cash and cash equivalents	30.97%26.14M	30.97%26.14M	-24.33%19.96M	-24.33%19.96M	-25.15%26.37M	--26.37M	252.33%35.23M	--10M
-Accounts receivable	23.18%63.26M	23.18%63.26M	-20.86%51.35M	-20.86%51.35M	47.08%64.89M	--64.89M	-17.85%44.12M	--53.7M
-Notes receivable	10.35%3.4M	10.35%3.4M	13.68%3.08M	13.68%3.08M	6.10%2.71M	--2.71M	--2.56M	----
-Other receivables	14.62%26.82M	14.62%26.82M	-28.49%23.4M	-28.49%23.4M	27.80%32.72M	--32.72M	--25.6M	----
Current deferred assets	----	----	4,696.15%1.25M	4,696.15%1.25M	--26K	--26K	----	----
Total current assets	15.21%133.6M	15.21%133.6M	-18.84%115.96M	-18.84%115.96M	21.88%142.87M	--142.87M	39.06%117.23M	--84.3M
Non current assets
-Accumulated depreciation	-10.83%-129.79M	-10.83%-129.79M	65.70%-117.1M	65.70%-117.1M	-44.30%-341.38M	---341.38M	---236.58M	----
-Long term equity investment	-5.13%204.19M	-5.13%204.19M	28.41%215.23M	28.41%215.23M	-25.19%167.61M	--167.61M	12.48%224.06M	--199.2M
Non current note receivables	30.49%10.74M	30.49%10.74M	-12.61%8.23M	-12.61%8.23M	-39.71%9.42M	--9.42M	-32.94%15.63M	--23.3M
-Goodwill	-0.14%164.94M	-0.14%164.94M	-0.14%165.17M	-0.14%165.17M	46.49%165.4M	--165.4M	9.09%112.91M	--103.5M
Regulatory assets	10.48%81.43M	10.48%81.43M	-19.10%73.71M	-19.10%73.71M	44.68%91.11M	--91.11M	17.27%62.98M	--53.7M
Liabilities
Current liabilities
Current debt and capital lease obligation	3.59%104.71M	3.59%104.71M	6.67%101.09M	6.67%101.09M	34.98%94.77M	--94.77M	9.36%70.21M	--64.2M
-Current debt	----	----	----	----	----	----	36.67%-190K	---300K
-Current capital lease obligation	3.59%104.71M	3.59%104.71M	6.67%101.09M	6.67%101.09M	34.62%94.77M	--94.77M	9.14%70.4M	--64.5M
-accounts payable	45.76%26.19M	45.76%26.19M	-32.12%17.97M	-32.12%17.97M	55.47%26.47M	--26.47M	-57.44%17.03M	--40M
-Total tax payable	-4.91%207.59M	-4.91%207.59M	28.18%218.32M	28.18%218.32M	-24.84%170.32M	--170.32M	11.25%226.61M	--203.7M
-Other payable	86.14%2.07M	86.14%2.07M	640.67%1.11M	640.67%1.11M	--150K	--150K	----	----
Current provisions	3.78%1.59M	3.78%1.59M	-79.37%1.54M	-79.37%1.54M	26.56%7.44M	--7.44M	-86.76%5.88M	--44.4M
Current deferred liabilities	40,350.00%3.24M	40,350.00%3.24M	-99.86%8K	-99.86%8K	39.75%5.62M	--5.62M	-44.19%4.02M	--7.2M
Current liabilities	10.52%207.7M	10.52%207.7M	-16.54%187.93M	-16.54%187.93M	35.50%225.16M	--225.16M	6.59%166.18M	--155.9M
Non current liabilities
-Long term debt	-0.28%149.13M	-0.28%149.13M	-10.78%149.54M	-10.78%149.54M	34.58%167.61M	--167.61M	30.28%124.54M	--95.6M
Non current accrued expenses	-2.33%281.7M	-2.33%281.7M	-7.02%288.44M	-7.02%288.44M	35.49%310.2M	--310.2M	17.65%228.94M	--194.6M
Long term provisions	-16.18%55.06M	-16.18%55.06M	--65.7M	--65.7M	----	----	-3.95%99.51M	--103.6M
Employee benefits	10.35%3.4M	10.35%3.4M	13.68%3.08M	13.68%3.08M	6.10%2.71M	--2.71M	--2.56M	----
Regulatory liabilities	-75.97%-9.87M	-75.97%-9.87M	-33.51%-5.61M	-33.51%-5.61M	-79.29%-4.2M	---4.2M	---2.34M	----
Preferred securities outside stock equity	1.89%44.62M	1.89%44.62M	-5.49%43.79M	-5.49%43.79M	8.33%46.33M	--46.33M	--42.77M	----
Total non current liabilities	2.23%415.3M	2.23%415.3M	2.72%406.24M	2.72%406.24M	0.69%395.49M	--395.49M	9.23%392.79M	--359.6M
Shareholders'equity
Share capital	-0.05%791.76M	-0.05%791.76M	-0.11%792.14M	-0.11%792.14M	-0.62%793.03M	--793.03M	1,594.21%797.98M	--47.1M
-common stock	-0.05%791.76M	-0.05%791.76M	-0.11%792.14M	-0.11%792.14M	-0.62%793.03M	--793.03M	1,594.21%797.98M	--47.1M
Gains losses not affecting retained earnings	0.22%-773.29M	0.22%-773.29M	0.24%-774.96M	0.24%-774.96M	0.19%-776.81M	---776.81M	---778.27M	----
Other equity interest	12.18%709K	12.18%709K	-44.27%632K	-44.27%632K	8.10%1.13M	--1.13M	-83.61%1.05M	--6.4M
Total equity	2.44%593.06M	2.44%593.06M	-7.82%578.91M	-7.82%578.91M	32.30%628.04M	--628.04M	16.72%474.7M	--406.7M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data